Association Between Conformity With Performance Measures and 1-Year Postdischarge Survival in Patients With Acute Decompensated Heart Failure

American Journal of Medical Quality

Volumn 28, Issue 2, 2013, Pages 160-168

  Scrutinio, Domenico ^a   Passantino, Andrea ^a   Ricci, Vito Antonio ^a   Catanzaro, Raffaella ^a  

^a Institute of Cassano Murge   (Italy)

Author keywords

acute decompensated heart failure; performance measures; survival

Indexed keywords

EID: 84874774500     PISSN: 10628606     EISSN: 1555824X     Source Type: Journal    
DOI: 10.1177/1062860612451049     Document Type: Article

References (37)

1. The Joint Commission. Specifications manual for national hospital inpatient quality measures. http://www.jointcommission.org/specifications_manual_for_national_hospital_inpatient_quality_measures. Accessed December 5, 2011.
2. Bonow RO,Bennett S,Casey DE, et al.ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. Circulation.18. 2005;112:.
3. Fonarow GC,Abraham WT,Albert NM, et al.Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design.Am Heart J. 2004;148:43-51.
4. Fonarow GC,Yancy CW,Albert NM, et al.Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry.Am Heart J. 2007;154:12-38.
5. Krumholz HM,Norman S-LT,Spertus JA,Shahian M,Bradley EH.Measuring performance for treating heart attack and heart failure: the case for outcomes measurement.Health Aff (Millwood). 2007;26:75-85.
6. Romano PS.Improving the quality of hospital care in America.N Engl J Med. 2005;353:302-304.
7. Stevenson LW.Counting performance with therapies for heart failure: aiming for quality or quantity?.Circulation. 2010;122:561-566.
8. Ghaly JK,Massie BM,Mann DL,Rich MW.Heart failure guidelines, performance measures, and the practice of medicine.J Am Coll Cardiol. 2010;56:2077-2080.
9. Felker GM,Pang PS,Adams KF, et al.Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward.Circ Heart Fail. 2010;3:314-325.
10. Chassin MR,Loeb JM,Schmaltz SP,Wachter RM.Accountability measures-using measurements to promote quality improvement.N Engl J Med. 2010;363:683-688.
11. Luthi JC,McClellan WM,Fitzgerald D, et al.Mortality associated with the quality of care of patients hospitalized with congestive heart failure.Int J Qual Health Care. 2002;14:15-24.
12. Fonarow GC,Abraham WT,Albert NM, et al.Association between performance measures and clinical outcomes for patients hospitalized with heart failure.JAMA. 2007;297:61-70.
13. Patterson ME,Hernandez AF,Hammill BG, et al.Process of care performance measures and long-term outcomes in patients hospitalized with heart failure.Med Care. 2010;48:210-216.
14. Fonarow GC,Abraham WT,Albert NM, et al.Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).Am Heart J. 2007;153 82:e11.
15. Kfoury AG,French TK,Horne BD, et al.Incremental survival benefit with adherence to standardized heart failure core measures: a performance evaluation study of 2958 patients.J Card Fail. 2008;14:95-102.
16. Hernandez AF,Hammill BG,Peterson ED, et al.Relationships between emerging measures of heart failure processes of care and clinical outcomes.Am Heart J. 2010;159:406-413.
17. Fonarow GC.Performance measures for patients hospitalized with heart failure: are they predictive of clinical outcomes?.Congest Heart Fail. 2007;13:342-346.
18. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of COPD. http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.html. Accessed May 16, 2012 18.
19. Dickstein K,Cohen-Solal A,Filippatos G, et al.ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology: developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).Eur Heart J. 2008;29:2388-2442.
20. Executive summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline.J Card Fail. 2010;16:475-539.
21. Hunt SA,Abraham WT,Chin MH, et al.2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation.Circulation. 2009;119:e391-e479.
22. Fonarow GC.Epidemiology and risk stratification in acute heart failure.Am Heart J. 2008;155:200-207.
23. Stevenson LW,Miller LW,Desvigne-Nickens P, et al.Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).Circulation. 2004;110:975-981.
24. Harjola V-P,Follath F,Nieminen MS, et al.Characteristics, outcomes, and predictors of mortality at 3 months and 1 year in patients hospitalized for acute heart failure.Eur J Heart Fail. 2010;12:239-248.
25. Lee DS,Ghosh N,Floras JS, et al.Association of blood pressure at hospital discharge with mortality in patients diagnosed with heart failure.Circ Heart Fail. 2009;2:616-623.
26. Klein L,Massie BM,Leimberger JD, et al.Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).Circ Heart Fail. 2008;1:25-33.
27. D'Agostino RB.Propensity scores in cardiovascular research.Circulation. 2007;115:2340-2343.
28. Ortolani P,Balducelli M,Marzaroli P, et al.Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.Circulation. 2008;117:923-930.
29. Chikwe J,Goldtsone AB,Passage J, et al.A propensity score-adjusted retrospective comparison of early and mid-term results of mitral valve repair versus replacement in octogenarians.Eur Heart J. 2011;32:618-626.
30. Shah B,Hernadez AF,Liang L, et al.Hospital variation and characteristics of implantable cardioverter-defibrillator use in patients with heart failure: data from the GWTG-HA (Get with the Guidelines-Heart Failure) Registry.J Am Coll Cardiol. 2009;53:416-422.
31. Fonarow GC,Albert NM,Curtis AB, et al.Associations between outpatient heart failure process-of-care measures and mortality.Circulation. 2011;123:1601-1610.
32. Nieminen MS,Brutsaert D,Dickstein K, et al.EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.Eur Heart J. 2006;27:2725-2736.
33. Peterson PN,Rumsfeld JS,Liang L, et al.Treatment and risk in heart failure: gaps in evidence or quality?.Circ Cardiovasc Qual Outcomes. 2010;3:309-315.
34. Patel UD,Hernandez AF,Liang L, et al.Quality of care and outcomes among patients with heart failure and chronic kidney disease: a Get with the Guidelines-Heart Failure Program study.Am Heart J. 2008;156:674-681.
35. The CONSENSUS Trial Study Group.N Engl J Med. 1987;316:1429-1435.
36. Masoudi FA,Rathore SS,Wang Y, et al.National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction.Circulation. 2004;110:724-731.
37. Berger AK,Duval S,Manske C, et al.Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.Am Heart J. 2007;153:1064-1073.